IP Library Patent Application 16901956
Patent Application
App. No. 16/901,956

CONDITIONALLY IMMORTALIZED LONG-TERM STEM CELLS AND METHODS OF MAKING AND USING SUCH CELLS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/901,956
Abstract

Disclosed are methods for conditionally immortalizing stem cells, including adult and embryonic stem cells, the cells produced by such methods, therapeutic and laboratory or research methods of using such cells, and methods to identify compounds related to cell differentiation and development or to treat diseases, using such cells. A mouse model of acute myeloid leukemia (AML) and cells and methods related to such mouse model are also described.

Claims (12)

1 .- 55 . (canceled)

56 . A method for promoting cell proliferation and cell survival of one or more adult stem cells cultured in vitro comprising:

contacting the one or more adult stem cells in vitro with a fusion protein, wherein the fusion comprises:

(a) a protein transduction domain of a Tat protein; and

(b) a MYC protein that is attached to the protein transduction domain of the Tat protein; and

culturing the one or more adult stem cells in a media;

wherein the cell survival and cell proliferation of the one or more adult stem cells is increased as compared with corresponding cells not exposed to the fusion protein.

57 . The method of claim 56 , wherein the one or more adult stem cells is selected from the group consisting of: hematopoietic stem cells, intestinal stem cells, osteoblastic stem cells, mesenchymal stem cells, neural stem cells, epithelial stem cells, cardiac myocyte progenitor stem cells, skin stem cells, skeletal muscle stem cells, and liver stem cells.

58 . A modified adult stem cell comprising a fusion protein, wherein the fusion comprises:

(a) a protein transduction domain of a Tat protein; and

(b) a MYC protein that is attached to the protein transduction domain of the Tat protein.

59 . The adult stem cell of claim 58 , wherein the adult stem cell is selected from among wherein the adult stem cells are selected from the group consisting of: hematopoietic stem cells, intestinal stem cells, osteoblastic stem cells, mesenchymal stem cells, neural stem cells, epithelial stem cells, cardiac myocyte progenitor stem cells, skin stem cells, skeletal muscle stem cells, and liver stem cells.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: REFAELI, YOSEF; TURNER, BRIAN CURTIS
To: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
Reel/Frame 053005/0151 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: CAMBIER, JOHN C.; JOHNSON, SARA ANN
To: THE REGENTS OF THE UNIVERSITY OF COLORADO
Reel/Frame 053005/0265 →
CHANGE OF NAME Recorded Jun 22, 2020
From: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
To: NATIONAL JEWISH HEALTH
Reel/Frame 053007/0011 →